Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Cetuximab.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Cetuximab.
Anthrax immune globulin, human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Cetuximab.
Advertisement
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Cetuximab.
BCG, Live, Connaught Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Cetuximab.
BCG, Live, Tice Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Cetuximab.
Advertisement
Belimumab
The risk or severity of adverse effects can be increased when Cetuximab is combined with Belimumab.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Cetuximab.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Cetuximab.
Advertisement
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Cetuximab.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Cetuximab.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Cetuximab.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Cetuximab.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Cetuximab.
Digoxin
Digoxin may decrease the cardiotoxic activities of Cetuximab.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Cetuximab.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Cetuximab.
Hepatitis A Vaccine, Inactivated
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Cetuximab.
Hepatitis B Surface Antigen Vaccine
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Cetuximab.
Ouabain
Ouabain may decrease the cardiotoxic activities of Cetuximab.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Cetuximab.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Cetuximab.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Cetuximab.
Rabies Immune Globulin, Human
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Cetuximab.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Cetuximab.
ROTAVIRUS VACCINE, LIVE
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Cetuximab.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Cetuximab.
Salmonella enterica subsp. enterica serovar typhi
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Cetuximab.
Tetanus Toxoid Vaccine, Inactivated
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Cetuximab.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Cetuximab.
Typhoid Vaccine Live Ty21a
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Cetuximab.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The therapeutic efficacy of Salmonella typhi ty2 vi polysaccharide antigen can be decreased when used in combination with Cetuximab.
Varicella Virus Vaccine Live (Oka-Merck) strain
The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Cetuximab.
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Cetuximab.
Yellow-Fever Virus Vaccine, 17D-204 strain
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Cetuximab.
